Live Breaking News & Updates on Stuart Rich

Stay updated with breaking news from Stuart rich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tenax Reports Publication of Phase 2 HELP Study to Evaluate Patients with Pulmonary Hypertension and Heart Failure | Tenax Reports Publication of Phase 2 HELP Study to Evaluate Patients with Pulmonary Hypertension and Heart FailureFinancial Buzz


25
Tenax Therapeutics, Inc. (NASDAQ: TENX)announced positive data from its Phase 2 HELP Study that evaluated levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.  Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Placebo-Controlled HELP Trial was published in the Journal of American College of Cardiology: Heart Failure.
The publication had a 84% responder rate during the open label phase as 37 or 44 patients met responder criteria and were randomized to levosimendan (n=18) or placebo (n=19).  Levosimendan did not significantly reduce the primary endpoint of exercise-PCWP but has reduced PCWP measured across all exercise stages.  The 6 week study design utilized invasive cardiovascular hemodynamics and secondary clinical endpoints that include a 6 minute walk test. ....

Daniel Burkhoff , Circulatory Support Research At Cardiovascular Foundation , Journal Of American College Cardiology , Tenax Therapeutics Inc , Tenax Therapeutics , Levosimendan Improves Hemodynamics , Exercise Tolerance , American College , Heart Failure , Mechanical Circulatory Support Research , Cardiovascular Research Foundation , Stuart Rich , Chief Medical Officer , Principal Investigator , இதழ் ஆஃப் அமெரிக்கன் கல்லூரி இருதயவியல் , உடற்பயிற்சி சகிப்புத்தன்மை , அமெரிக்கன் கல்லூரி , இதயம் தோல்வி , இருதய ஆராய்ச்சி அடித்தளம் , ஸ்டூவர்ட் பணக்கார , தலைமை மருத்துவ அதிகாரி , ப்ரிந்ஸிபல் புலனாய்வாளர் ,

4 Penny Stocks To Buy With Analysts Expecting 80%-180% Upside


4 Penny Stocks To Buy With Analysts Expecting 80%-180% Upside
These Penny Stocks Have Analysts Bullish Right Now
71 views
Author
Are Analysts Right About These Penny Stocks?
Penny stocks are some of the highest-risk stocks in the market. Thanks to a long history of volatility, manipulation, hype, and speculation, traders seek the ultimate alpha in these cheap shares. But it isn’t just for “wild west” gun-slinging traders. Analysts have also grown bullish on many stocks under $5.
Small-cap stocks are synonymous with “penny stocks.” Usually, a benchmark for sentiment, the Russell 2000 Small-Cap Index ETF (NYSE: IWM), has been followed closely to gauge momentum in smaller companies. Though not all penny stocks are “small-cap stocks,” it’s a term that’s loosely thrown around in the world of stocks under $5. ....

Canaccord Genuity , Jared Woodard Bof , Myles Hunter , David Dodd , American College Of Cardiology Heart Failure , Zovio Inc , University Of Arizona Global Campus , Maxim Group Has , Midam Ventures , Geovax Labs Inc , Childcare Education Institute , Sesen Bio Inc , University Of Arizona , Us Patent Trademark Office , Tenax Therapeutics Inc , Are Analysts Right About These Penny , Cap Index , Vax Labs , Stocks To Buy , Geovax Labs , Patent Application , Immune Response , Hepatitisb Virus , Penny Stocks To Buy In April , For Your Watch , Zika Virus ,